deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

APOLLO LIFE SCIENCES LIMITED (ASX.AOP)

ASX Announcements (courtesy of ASX)

20052006200720082009

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names
Shareholder links

 

REGISTRY:
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details
Address: Level 4 , The Read Buildings, 16 Milligan Street Perth WA 6000


Date first listed: 29/06/2005

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biopharmaceutical company which is creating, manufacturing and marketing next-generation therapeutics based on natural human proteins to protect and improve human health

name changed to Apollo Consolidated Limited

09/09/2009

releases a consolidation (1 for 20) timetable and that resolutions considered at the meeting yesterday were passed

05/08/2009

a General Meeting is to be held at 11:00 am (EST), on 4 August 2009 at the offices of Pitcher Partners, Level 22 MLC Centre, 19 Martin Place, Sydney, New South Wales to consider the restructure (including a consolidation of 1 for 20) and recapitalisation of the company

03/07/2009

the Deed Administrators report that creditors have resolved to accept a recapitalisation proposal

14/05/2009

the Deed Administrators report that Apollo's plant & equipment has been sold by auction and the marketing of its intellectual property continues - they are currently negotiating a proposal for the recapitalisation of Apollo - shareholders will be contacted with full details of the recapitalisation proposal shortly

10/02/2009

company enters into a Deed of Company Arrangement (DOCA) - the DOCA allows David Young and Anthony Elkerton, the Joint Deed Administrators time to conclude their investigations into Apollo's affairs and conclude their dealings in relation to the sale of Apollo's assets and/or restructure of its share capital with a view to re-listing Apollo on the ASX for the benefit of creditors and shareholders - the deadline for offers to be received for Apollo's assets is 16 January 2009

03/12/2008

creditors resolve to enter into a Deed of Company arrangement

26/11/2008

the administrators are offering the major assets of the company and its subsidiaries for sale

03/11/2008

company appoints administrators Anthony Elkerton and David Young of Pitcher Partners - this is never good for shareholders but it will be a month or so before a clearer picture emerges

24/10/2008

funding of $2m from John Priest previously reported as being secured is now not going to proceed

23/10/2008

releases preliminary final report

29/08/2008

none of the resolutions considered at today's general meeting were approved

19/08/2008

a general meeting of Apollo Life Sciences Limited ("Company") will be held on 19 August 2008 at 10.00 a.m. at 147 Queen Street, Beaconsfield NSW 2015

21/07/2008

company confirms the restructuring phase of its three-phase program is almost complete and the consolidation phase about to begin

04/07/2008

company advises a meeting of shareholders has been requisitioned and it will advise details to shareholders later

23/06/2008

advises of the signing of an agreement regarding the licensing of its research proteins business

10/06/2008

announces the signing of a Heads of Agreement regarding the licensing of its research proteins business

16/05/2008

releases its quarterly cash report to 31 March 2008 showing a deficit at operating level for the quarter of $1.78m

30/04/2008

company announces it has engaged Deloitte Touche Tohmatsu to advise the Apollo Board of Directors on their restructure of the Apollo business and in particular the strategic sale of certain business assets owned by Apollo

23/04/2008

the company confirms that it is currently implementing its notified restructure strategy with a three stage process of restructuring, consolidation and value-creation - the restructuring, which includes the orderly realisation of non-core assets as a going concern with an aim to pay creditors in full, is scheduled to continue through to June

15/04/2008

Apollo is implementing its notified strategy of reducing costs and realising non-core assets - as part of the cost reduction process, the retainer-based contracts of Diabetes Advisory Board members which expired in March have not been renewed - the majority of full scientific advisory board members, including researchers with expertise in the diabetes field, are engaged on a different basis and continue in their roles

01/04/2008

securities of Apollo Life Sciences Limited (the "Company") will be suspended from quotation immediately, at the request of the Company in accordance with listing rule 17.2, following the Company's announcement in relation to a strategic review involving the sale of assets and uncertainty relating to the ability of the Company to operate as a going concern

18/03/2008
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Timothy BlackwellCFO16/05/2007
    Alex NeulingCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    John PriestChairman, CEO12/09/200204/08/2009
    Tony BastenDirector04/08/2009
    Paul MurnaneDirector22/04/200404/08/2009
    Gregory Russell-JonesDirector25/05/200619/06/2007

    Date of first appointment, title may have changed.